TEVA FY 2020 Earnings — Teva Pharmaceutical Industries Limited Revenue & Financial Results | Market Cap Arena

TEVATeva Pharmaceutical Industries Limited

$37B

FY 2020 Earnings

Healthcare Drug Manufacturers - Specialty & Generic

Income Statement

Revenue

$16.7B-1.4% YoY

Gross Profit

$7.7B46.4% margin

Operating Income

-$3.6B-21.4% margin

Net Income

-$4.0B-24.0% margin

EPS (Diluted)

$-3.64

Cash Flow

Operating Cash Flow

$1.2B

Free Cash Flow

$638M

Stock-Based Comp.

$129M

Balance Sheet

Total Assets

$50.6B

Total Liabilities

$39.6B

Stockholders' Equity

$10.0B

Cash & Equivalents

$2.2B

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$16.7B	$16.9B	-1.4%
Gross Profit	$7.7B	$7.5B	+2.5%
Operating Income	-$3.6B	-$443M	-706.3%
Net Income	-$4.0B	-$999M	-299.4%